Selected article for: "immune system and th1 cell"
Author: Zhelezova, Galina; Mateeva, Valeria; Mateev, Grisha
Title: Is the BCG vaccine a useful tool against COVID-19?
  • Cord-id: 1bzaii6a
  • Document date: 2020_12_16
    • ID: 1bzaii6a
    Snippet: The Bacillus Calmette–Guérin (BCG) vaccine has been used since 1921 initially for protection against tuberculosis. BCG acts through stimulation of cell-mediated adaptive immunity with activation of the Th1 cells and production of interferon gamma. Additionally, it is able to stimulate the immune system in a nonspecific manner, which results in effectiveness of the BCG against non-mycobacterial infections and in some malignant, autoimmune, and inflammatory diseases. Recently, its potential use
    Document: The Bacillus Calmette–Guérin (BCG) vaccine has been used since 1921 initially for protection against tuberculosis. BCG acts through stimulation of cell-mediated adaptive immunity with activation of the Th1 cells and production of interferon gamma. Additionally, it is able to stimulate the immune system in a nonspecific manner, which results in effectiveness of the BCG against non-mycobacterial infections and in some malignant, autoimmune, and inflammatory diseases. Recently, its potential use in the fight against the coronavirus disease 2019 (COVID-19) pandemic has been suggested. This is based upon the concept of BCG-induced trained innate immunity—a memory-like response of the innate immune system that can realize greater protection in case of re-infection. This hypothesis represents a milestone in the potential use of the BCG vaccine in the fight with the novel coronavirus.

    Search related documents:
    Co phrase search for related documents
    • acute inflammation and adaptive immune response: 1, 2, 3, 4
    • acute inflammation and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute inflammation and low mortality: 1, 2, 3
    • adaptive immune response and adjuvant effect: 1, 2
    • adaptive immunity and adjuvant effect: 1, 2
    • adaptive immunity and low birth weight: 1
    • adaptive immunity and low morbidity: 1
    • adaptive immunity and low mortality: 1, 2, 3
    • additional vaccination and local epidemiology: 1